SPRAVATO® (esketamine) approved in the U.S. as the first and …
Jan 21, 2025 · Titusville, New Jersey, January 21, 2025 – Johnson & Johnson (NYSE: JNJ) announced today the U.S. Food and Drug Administration (FDA) approval of a supplemental …
Spravato Nasal Spray Can Now Be Used Alone for Treatment …
Jan 28, 2025 · People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
What to Know About the New Nasal Spray for Tough Depression
Jan 27, 2025 · A study by Johnson & Johnson, the company that makes Spravato, showed that 22.5% of people using esketamine nasal spray achieved remission from major depression in …
Johnson & Johnson ketamine-derived nasal spray gets FDA …
Jan 22, 2025 · Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral antidepressants. On Tuesday, the Food and Drug …
FDA approves Johnson & Johnson’s nasal spray for depression …
The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow.
FDA approves first-of-its-kind nasal spray for severe depression
Jan 22, 2025 · Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive …
Janssen Announces U.S. FDA Approval of SPRAVATO - Johnson & Johnson
TITUSVILLE, N.J. – (August 3, 2020) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved …
FDA approves Spravato, first monotherapy nasal spray to treat ...
Jan 21, 2025 · Johnson & Johnson’s Spravato nasal spray has been approved to treat a major depressive disorder in adults who have had an inadequate response to at least two oral …
FDA approves standalone use of J&J's ketamine-derived …
Jan 21, 2025 · The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used as a standalone treatment for patients …
FDA Approves Johnson & Johnson’s Nasal Spray for Adults
Jan 21, 2025 · The U.S. Food and Drug Administration (FDA) has approved a nasal spray to be used alone in adults with depression that is difficult to treat. On Tuesday, the FDA cleared the …